tamir biotechnology inc product pipeline review  trends share size research report uscanada toll free home global markets direct tamir biotechnology inc product pipeline review  tamir biotechnology inc product pipeline review  published by  global markets direct published date  nov  category  no of pages   pages description table of content check discount tamir biotechnology inc product pipeline review  global market directs pharmaceuticals report tamir biotechnology inc product pipeline review  provides data on the tamir biotechnology incs research and development focus the report includes information on current developmental pipeline complete with latest updates and features on discontinued and dormant projects  this report is built using data and information sourced from global markets directs proprietary databases tamir biotechnology incs corporate website sec filings investor presentations and featured press releases both from tamir biotechnology inc and industryspecific third party sources put together by global markets directs team  scope tamir biotechnology inc brief tamir biotechnology inc overview including business description key information and facts and its locations and subsidiaries review of current pipeline of tamir biotechnology inc human therapeutic division overview of pipeline therapeutics across various therapy areas coverage of current pipeline molecules in various stages of drug development including the combination treatment modalities across the globe product profiles for late stage and clinical stage products of tamir biotechnology inc with complete description of the products developmental history mechanism of action therapeutic class target and major milestones  recent updates of the tamir biotechnology incs pipeline in the last quarter  key discontinued and dormant projects  latest news and deals relating to the products reasons to buy evaluate tamir biotechnology incs strategic position with total access to detailed information on its product pipeline  assess the growth potential of tamir biotechnology inc in its therapy areas of focus  identify new drug targets and therapeutic classes in the tamir biotechnology incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas  exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps  exploit collaboration and partnership opportunities with tamir biotechnology inc  avoid intellectual property rights related issues  explore the dormant and discontinued projects of tamir biotechnology inc and identify potential opportunities in those areas table of contents table of contents list of tables list of figures tamir biotechnology inc snapshot tamir biotechnology inc overview key information key facts tamir biotechnology inc research and development overview key therapeutic areas tamir biotechnology inc pipeline review pipeline products by stage of development pipeline products monotherapy pipeline products combination treatment modalities tamir biotechnology inc pipeline products glance tamir biotechnology inc early stage pipeline products preclinical productscombination treatment modalities discovery productscombination treatment modalities tamir biotechnology inc drug profiles ac product description mechanism of action rd progress natural amphinase product description mechanism of action rd progress p product description mechanism of action rd progress ramphinase  cladribine  fludarabine product description mechanism of action rd progress ramphinase  cytarabine arabinoside product description mechanism of action rd progress ramphinase  doxorubicin product description mechanism of action rd progress ramphinase  product description mechanism of action rd progress ranpirnase product description mechanism of action rd progress ranpirnase  cladribine  fludarabine phosphate product description mechanism of action rd progress ranpirnase  cytarabine product description mechanism of action rd progress rn product description mechanism of action rd progress tamir biotechnology inc pipeline products by mechanism of action tamir biotechnology inc  dormant projects tamir biotechnology inc company statement tamir biotechnology inc locations and subsidiaries head office financial deals landscape tamir biotechnology inc deals summary tamir biotechnology inc pharmaceuticals  healthcare deal details partnerships alfacell enters into collaboration agreement with west german cancer center licensing agreements alfacell enters into licensing agreement with strativav pharma alfacell enters into licensing agreement with genesis pharma equity offering alfacell completes private placement of  million alfacell completes private placement of  million alfacell completes private placement of  million  appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer  list of table tamir biotechnology inc key information tamir biotechnology inc key facts tamir biotechnology inc pipeline by indication  tamir biotechnology inc pipeline by stage of development  tamir biotechnology inc monotherapy products in pipeline  tamir biotechnology inc combination treatment modalities in pipeline  tamir biotechnology inc preclinical  tamir biotechnology inc discovery  tamir biotechnology inc pipeline products by mechanism of action  tamir biotechnology inc  dormant developmental projects tamir biotechnology inc deals summary alfacell enters into collaboration agreement with west german cancer center alfacell enters into licensing agreement with strativav pharma alfacell enters into licensing agreement with genesis pharma alfacell completes private placement of  million alfacell completes private placement of  million alfacell completes private placement of  million  list of chart tamir biotechnology inc pipeline by indication  tamir biotechnology inc pipeline by stage of development  tamir biotechnology inc monotherapy products in pipeline  tamir biotechnology inc combination treatment modalities in pipeline  tamir biotechnology inc  pipeline products by mechanism of action   make an enquiry before buying this report please fill the enquiry form below full name  your email  job title  company  phone no  pls affix country code message security code   choose license type  select user license single license user  multiple license user  do you wish to check sample of this report order a sample report have query on this report related news amgen’s repatha gets fast fda review for additional heart benefits more than  of diabetic men have erectile dysfunction trex did not sprint it walked unhackable web communication to be launched by china tetraphases antibiotic eravacycline succeeds stage clinical trial research assistance we will be happy to help you find what you need please call us or write to us  uscanada toll free tel   email  salesresearchmozus tamir biotechnology inc private company information  bloomberg july    pm et biotechnology company overview of tamir biotechnology inc snapshot people company overview tamir biotechnology inc a biopharmaceutical company primarily engages in the discovery and development of a class of therapeutic drugs for the treatment of cancer and other pathological conditions its proprietary drug discovery and development program consists of therapeutics developed from amphibian ribonucleases the company’s lead drug product candidate onconase is evaluated in human clinical trials for the treatment of various forms of cancer tamir biotechnology also focuses on new drug application for unresectable malignant mesothelioma in addition it completed a phase i clinical trial for the treatment of nonsmall cell lung cancer the company was formerly known as alfacell c tamir biotechnology inc a biopharmaceutical company primarily engages in the discovery and development of a class of therapeutic drugs for the treatment of cancer and other pathological conditions its proprietary drug discovery and development program consists of therapeutics developed from amphibian ribonucleases the company’s lead drug product candidate onconase is evaluated in human clinical trials for the treatment of various forms of cancer tamir biotechnology also focuses on new drug application for unresectable malignant mesothelioma in addition it completed a phase i clinical trial for the treatment of nonsmall cell lung cancer the company was formerly known as alfacell corporation and changed its name to tamir biotechnology inc in april  tamir biotechnology inc was founded in  and is headquartered in san diego california detailed description  high bluff drivesuite san diego ca united statesfounded in  phone  fax  wwwalfacellcom key executives for tamir biotechnology inc ms jamie marie sulley chief executive officer president secretary and director age  ms joanne m barsa chief financial officer and secretary age  dr michele carbone md phd chairman of the thoracic cancer advisory board governor tommy g thompson jd special advisor to chief executive officer age  compensation as of fiscal year  tamir biotechnology inc key developments tamir biotechnology announces results from preclinical investigational study at institute of antiviral research feb   tamir biotechnology announced results from a preclinical investigational study at the institute of antiviral research at utah state university the study evaluated the antiviral activity of ranpirnase in an established cell model of zika virus infection overall the study revealed that ranpirnase was active in blocking zika virus relative to a control in previous cell based studies ranpirnase exhibited no cytotoxic effects at therapeutically effective dose levels the clinical work with the zika virus builds on years of work with other virallycaused pathologies such as ebola results from a recent nihsponsored study on the ebola virus gave  survival in ranpirnasetreated animals administered with therapeutic levels of the drug postinfection the virus was undetectable in the serum of ranpirnasetreated mice at eight days postinfection the companys clinical program is led by their phase ii investigation of a topical formulation of ranpirnase in the treatment of hpv genital warts this study is expected to begin enrollment in south america in february  there are an estimated  million new and recurrent hpv infections per year in the us alone and the global hpv market is estimated to be over usd  billion in  ranpirnase for injection has been safely administered to over  subjects in previous oncology clinical trials similar private companies by industry company name region n labs inc united states andme inc united states c tech corporation inc united states v biosciences inc united states bar biologics inc united states recent private companies transactions typedate target no transactions available in the past  months request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact tamir biotechnology inc please visit wwwalfacellcom company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one tamir biotechnology inc company information  drugscom skip to content search all allconsumerprofessionalpill idinteractionsnewsfda alertsapprovalspipelineclinical trialscare notesencyclopediadictionarynatural products browse all medications a b c d e f g h i j k l m n o p q r s t u v w x y z advanced search topics  tools facebook twitter google plus sign in sign in register menu home › pharmaceutical companies › tamir biotechnology inc print share tamir biotechnology inc address tamir biotechnology inc  high bluff dr suite  san diego ca contact detailsphone  website tamirbiocomcareers tamirbiocomcontact tamir biotechnology inc was formerly known as alfacell corporation latest drug information updates vosevi vosevi sofosbuvir  velpatasvir  voxilaprevir is a singletablet regimen for the treatment of adults withnerlynx nerlynx neratinib is a tyrosine kinase inhibitor for the extended adjuvant treatment of patients with earlytremfya tremfya guselkumab is an interleukin blocker indicated for the treatment of adult patients withbevyxxa bevyxxa betrixaban is an oral oncedaily factor xa inhibitor anticoagulant for the extendeddurationrituxan hycela rituxan hycela rituximab and hyaluronidase human is a subcutaneous monoclonal antibody and hyaluronidasebaxdela baxdela delafloxacin is a fluoroquinolone antibacterial indicated for the treatment of acute bacterial skin more drug information updates drugscom mobile apps the easiest way to lookup drug information identify pills check interactions and set up your own personal medication records available for android and ios devices explore apps support help center frequent questions sitemap contact us about about drugscom advertising policy content submissions drugscom blog terms  privacy editorial policy privacy policy terms of use attribution  citations facebook twitter google plus youtube rss feed subscribe to receive email notifications whenever new articles are published drugscom provides accurate and independent information on more than  prescription drugs overthecounter medicines and natural products this material is provided for educational purposes only and is not intended for medical advice diagnosis or treatment data sources include micromedex® updated july th  cerner multum™ updated july th  wolters kluwer™ updated july th  and others to view content sources and attributions please refer to our editorial policy third party advertising we comply with the honcode standard for trustworthy health information  verify here copyright   drugscom all rights reserved share on facebook share on twitter share on googleplus email to a friend hide tamir biotechnology inc  product pipeline review  q  tamir biotechnology inc  product pipeline review  q   global markets direct list price  our price  buy now  quantity  add to cart  itemitems in the cart  checkout used book price tamir biotechnology inc  product pipeline review  q   global markets direct publisher marketresearchcom availabilityavailable for download now sales rank isbn birhztkisbn birhzt tamir biotechnology inc  product pipeline review  q summaryglobal market directâ€™s pharmaceuticals report â€œtamir biotechnology inc  product pipeline review  q â€ provides data on the companyâ€™s research and development focus the report includes information on current developmental pipeline complete with latest updates and features on discontinued and dormant projects this report is built using data and information sourced from global markets directâ€™s proprietary databases companyâ€™s corporate website sec filings investor presentations and featured press releases both from company and industryspecific third party sources put together by global markets directâ€™s team scopetamir biotechnology inc  brief company overview including business description key information and facts and its locations and subsidiariesreview of current pipeline of tamir biotechnology inc human therapeutic divisionoverview of pipeline therapeutics across various therapy areascoverage of current pipeline molecules in various stages of drug development including the combination treatment modalities across the globeproduct profiles for late stage and clinical stage products of tamir biotechnology inc with complete description of the productâ€™s developmental history mechanism of action therapeutic class target and major milestones recent updates of the tamir biotechnology incâ€™s pipeline in the last quarter key discontinued and dormant projects latest news and deals relating to the productsreasons to buyevaluate tamir biotechnology incâ€™s strategic position with total access to detailed information on its product pipeline assess the growth potential of tamir biotechnology inc in its therapy areas of focus identify new drug targets and therapeutic classes in the tamir biotechnology incâ€™s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps exploit collaboration and partnership opportunities with tamir biotechnology inc avoid intellectual property rights related issues explore the dormant and discontinued projects of tamir biotechnology inc and identify potential opportunities in those areas now you can buy books online in usauk and india terms and conditions apply disclaimer all product data on this page belongs to  no guarantees are made as to accuracy of prices and information similar books in category everything else  academic library automation view details the art of falling apart  short tales of ordinary madness view details how to build your dream cabin in the woods the ultimate guide to building and maintaining a backcountry getaway view details an introduction to the study of astrology with numerous emendations adapted to the improved state of the science view details the battleship bismarck topdrawings view details the baby sleep book the complete guide to a good nights rest for the whole family sears parenting library view details francis the journey and the dream view details the girl in the italian bakery view details the attributes of man view details mössbauer spectroscopy applied to magnetism and materials science modern inorganic chemistry view details student resource center for eccouncils ethical hacking and countermeasures secure network infrastructures st edition view details introduction to linear regression analysis fifth edition set view details basic pattern cutting  cuttings for skirts blouses shirts dresses jackets pants german edition view details unruled composition notebook requested by college students the world over view details storie di fantasmi per il dopocena view details creating a world without poverty how social business can transform our lives view details eagle from the dawn an historical novel about lewis and clark and the nez perces the journals of kevin murphy book  view details playboy specialplaymates of the world collectors edition sept  view details con brio beginning spanish spanish edition rd edition by lucas murillo maria c dawson laila m  hardcover view details textbook of clinical neuroanatomy view details search for a specific title or author or isbn search you can search by title of bookpartial names allowed you can search by author of book partial names allowed you can search by subject eg physicschemistry partial names allowed you can search by isbn eg  digits or  digits isbn or asin of book without any spaces or hyphens shipping of books is available all over the world with few exceptions buying process is  secure contact us send message for any queries please dont hesitate to contact us at vinay garg usa  uk   india   tamir biotechnology inc  company profile from hoover’s  db hoovers menu buy reports  lists how it works united states united kingdom   login company people industry search db hoovers company  people  industry login avention onesource is now db hoovers login here for access to db hoovers db datavision db business browser and isell login for customers of hoovers prior to march   login call   chat software by boldchat start free trial call   chat software by boldchat start free trial search the db hoovers database company company people industry home company information company search company overview  profile company profile information for sales preparation marketing contacts competition revenue  financial available products company report biotechnology product manufacturing industry report tamir biotechnology inccompany information  oberlin drsan diego ca  united states  † httpwwwalfacellcom top  competitors immunogen inc eli lilly and company merck  co inc unlock more access to hoover’s build customized email lists  based on your best customer profile learn more about the companies you want to sell to hoover’s has reports on  million companies and  industries  data points are updated each day get real insight written by real people – exclusive research and reviews by our inhouse editorial staff we can deliver our data to your desktop to excel direct to your crm into your custom app or via mobile request your free trial call   today to get started with a free trial   tamir biotechnology inc company profile developmentstage tamir biotechnology formerly alfacell is willing to kiss a few frogs in hopes one will transform into a princely product the biotechnology firm has isolated proteins from northern leopard frog eggs and embryos as possible therapies for cancerous tumors that have become resistant to chemotherapy the companys lead drug candidate onconase is being studied as a possible treatment for a variety of cancers including nonsmall cell lung cancer tamir biotechnology is researching applications for onconase and other amphibian proteins for applications in other areas of oncology as well as infectious diseases † some telephone numbers on the hoover’s site may be on a country’s do not call or do not contact list including but not limited to the united kingdom’s ctps or tps registers it is a legal requirement that companies do not make sales or marketing calls to registered numbers these are central opt out registers whereby corporate subscribers and individuals can register their preference not to receive unsolicited sales and marketing telephone calls by using the information provided on the hoover’s sites as the direct marketer you represent and warrant that you will use such information in compliance with all applicable local state national or international laws and regulations including any local do not call registers or marketing regulations and agree to defend indemnify and hold harmless dun  bradstreet and each of its affiliates in the event your use violates such laws and regulations additional tamir biotechnology inc information sales preparation get relevant industry context to prepare for your next sales call – trends competitors news call prep questions and more marketing campaigns find prospect companies that meet the profile of your best customers to maximize campaign roi strategy  planning identify new market opportunities and new strategies for existing markets credit management  finance determine and track a company’s financial condition related tags san diego ca united states biotechnology product manufacturing free alerts to changes in your db® credit scores sign up get creditsignal® for free try db credit free for  days get started try db credit free for  days tamir biotechnology inc  san diego  ca  company information products resources my account talk to a db advisor  business directory ca san diego biological products except diagnostic biological products except diagnostic tamir biotechnology inc t tamir biotechnology inc claim this business  oberlin dr san diego ca  get directions   wwwalfacellcom business info founded  incorporated annual revenue  employee count  industries biological products except diagnostic contacts jamie sulley contact business your email address subject message send message company summary tamir biotechnology inc is located at  oberlin dr in san diego and has been in the business of biological products except diagnostic since  verified status unverified address unverified last verified  phone unverified payment method unverified view full report similar businesses nearby our similar businesses nearby shows similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile competitive landscape our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile payments accepted no data hours sunday   monday   tuesday   wednesday   thursday   friday   saturday   t view additional data select from over  networks below to view available data about this business if this data is unavailable or inaccurate and you own or represent this business click here for more information on how you may be able to correct it credibility review google facebookcom yellowbookcom bingcom yellowpagescom merchantcircle tele atlas tomtom twittercom aol mapquest yahoo local applesiri groupon hotfrogcom comcastnet search reachlocal admedia dealsplus shoptopiacom alteryx dogtime media kslcom sirtune americantownscom driverside kudzucom specialsagentcom answerscom egood lawinfocom spotlikescom anywhocom egumball likenesscom spotzot eservicelog mapmyrun technocom apartmentguidecom ezlocalcom eztousecom teleroute aroundmecom metropolistcom therapistscom atlanta newhomes findlawcom time out new york avantar findthebestcom mojopagescom bb yellowpages fivestar software mycitywaycom tripadvisor bckyrdcom giftcardscom mycouponscom beachcaliforniacom golocalcom mymovecom upmesocialcom belo goodinfo newsgazette nokia usdirectorycom carscom nomao centzycom hibu openlistcom chacha search homeplatecom ownlocalcom visikard challamacom homestore patchcom voltari citybot pelopidas vouchd classifiedads hostway placeiq walkscorecom cloudmade hoodoyou planetdiscovercom weddingwirecom powerprofiles where inc contractorscom igolocalcom radiate media wikiocity couponmap indeedcom wimgocom crowdspot innova electronics intellistrand realtorcom datasphere inthemocom replycom yellowbotcom jiwire rocket fuel yellowpagecitycom dmvorg justclicklocalcom dirxion keencom zidstercom photos business credit report receive a onetime comprehensive credit report on this company get full credit report facebook twitter yelp call  to speak with a db advisor today customer resources products education center business articles  insights glossary contact us customer support communication preferences search for db duns our company about us company history business credit history careers press releases news success stories hoovers our network partners affiliates blog access to capital entrepreneurial initiative db international supplieredge site links business directory site map pipeda privacy policy website terms of service product license agreement  dun  bradstreet inc  all rights reserved microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft partnering  tamir biotechnology inc partnering partner with us tamirbio is interested in exploring partnerships or licensing opportunities for our broad spectrum antiviral for inquiries contact infotamirbiocom back to top tamir biotechnology inc we are an innovative therapeutics company engaged in developing therapies for the treatment of human viral diseases our efforts focus on the treatment of conditions with high unmet medical need including human papilloma virus hpv cytomegalovirus cmv influenza hepatitis c and ebola learn more back to top about  tamir biotechnology inc about company overview   tamirbio is a clinical stage antiviral therapeutics company engaged in the discovery and development of a new class of prophylactic and therapeutic drugs for the treatment of viruses and other pathological conditions tamirbio’s first target is the human papilloma virus hpv the worldwide leading cause of genital warts throughout  and the first half of  tamirbio operations were successfully restructured including privatization of the company to support the antiviral focus along with attracting a strong team of experienced biotechnology professionals the company has since successfully advanced its clinical pipeline including completion of a randomized controlled doubleblinded phase ii study in patients with genital warts in addition the organization’s preclinical activities have documented broadspectrum activity against all viral families along with securing independent third party validation of antiviral properties for its leading licensing candidates   management tamirbio is managed by senior executives with extensive experience in developing therapies to market back to top tamir biotechnology inc we are an innovative therapeutics company engaged in developing therapies for the treatment of human viral diseases our efforts focus on the treatment of conditions with high unmet medical need including human papilloma virus hpv cytomegalovirus cmv influenza hepatitis c and ebola learn more back to top platform  tamir biotechnology inc platform technology ranpirnase a ribonuclease rnase is a member of the superfamily of enzymes which catalyze the degradation of rna and mediate several essential biological activities namely regulation of cell proliferation maturation differentiation and cell death therefore they are ideal candidates for the development of therapeutics for lifethreatening diseases including ebola and autoimmune diseases that require antiproliferative and apoptotic properties rnases are a superfamily of enzymes which catalyze the degradation of rna ranpirnase overcomes the known challenges of targeting rna for therapeutic purposes   strong antiviral effect ranpirnase antiviral activity was greater than  of all compounds seen by rd party testing lab safety profile over  patients dosed in fda studies for cancer drug is known to be safe and should accelerate approval pathway ready formulation tamirbio topical antiviral application uses a wellunderstood proprietary transdermal delivery system physical properties a highly stable heatresistant singlechain protein of  amino acids molecular weight of  kda secure manufacturing tamirbio owns large quantity of rana pipiens eggs and previous oncologic activity means manufacturing understood mechanism of action the compound is derived from frog eggs and preferentially enters infected cells by degrading rna ranpirnase halts protein synthesis thus blocking viral replication ranpirnase is shown to target trna and premirna and has a mechanism similar to dicer cytoplasmic rnase iii in addition to blocking protein synthesis machinery the compound has been shown to upregulate genes involved in key cell functions including transcription regulation cell cycle apotosis as well as the immune and stress response publications kiesgen s liebers n cremer m arnold u et al a fusogenic dengue virusderived peptide enhances antitumor efficacy of an antibodyribonuclease fusion protein targeting the egf receptor protein eng des sel  oct youle rj wu yn mikulski sm shogen k et al rnase inhibition of human immunodeficiency virus infection of h cells proc natl acad sci u s a  jun  squiquera l taxman dj brendle sa torres r sulley j hodge t christensen n sidransky d et al ranpirnase eradicates human papillomavirus in cultured cells and heals anogenital warts in a phase i study antivir ther  jan  doi imp vert a castro j ribó m benito a vilanova m et al activating transcription factor  is crucial for antitumor activity and to strengthen the antiviral properties of onconase oncotarget  dec  doi oncotarget   back to top contact  tamir biotechnology inc contact address  jfk pkwy • st floor west suite  • short hills nj  phone    fax     email infotamirbiocom partner with us tamirbio is interested in exploring partnerships or licensing opportunities for our broad spectrum antiviral for inquiries fill out the form below or contact us at infotamirbiocom × thank you we will contact you shortly × ups an error occured please try again later send message back to top about  tamir biotechnology inc about company overview   tamirbio is a clinical stage antiviral therapeutics company engaged in the discovery and development of a new class of prophylactic and therapeutic drugs for the treatment of viruses and other pathological conditions tamirbio’s first target is the human papilloma virus hpv the worldwide leading cause of genital warts throughout  and the first half of  tamirbio operations were successfully restructured including privatization of the company to support the antiviral focus along with attracting a strong team of experienced biotechnology professionals the company has since successfully advanced its clinical pipeline including completion of a randomized controlled doubleblinded phase ii study in patients with genital warts in addition the organization’s preclinical activities have documented broadspectrum activity against all viral families along with securing independent third party validation of antiviral properties for its leading licensing candidates   management tamirbio is managed by senior executives with extensive experience in developing therapies to market back to top pipeline  tamir biotechnology inc pipeline hpv tamirbio initial clinical target is the treatment of genital warts caused by hpv worldwide there are  million new and recurrent genital wart infections caused by hpv the most common sexually transmitted disease today’s therapeutic options all have shortcomings including high rates of recurrence the need for continued application or invasiveness tamirbio asserts that clinicians and patients will adopt a topically applied option that demands only  applications with a high safety profile  billion tamirbio estimates the total hpv market opportunity at b th largest threat  the us center for disease control and prevention cdc has named hpv the th largest health threat the us will face in   while several types of hpv have been linked with cervical cancer hpv types  and  are thought to account for roughly  of all cervical cancer cases  persistent hpv infection in the anal region is thought to be responsible for up to  of anal cancers k according to the cdc the number of people who contract genital warts in the us every year tamirbio is currently enrolling a phase i ous study of topical ranpiranse for anogential warts results are expected in q  additional clinical pursuits beyond hpv tamirbio has documented considerable antiviral activity for the following licensing opportunities ebola ebv tamirbio ranpirnase is actively being considered as a standalone or adjuvant therapy in an effort to battle the recent worldwide ebv outbreaks orthomyxoviruses influenza reported to be between  and  million deathsyear from influenza middle east respiratory syndrome merscov expanding disease outbreak with a total of just under  cases confirmed by world health organization hepatitis c virus hcv costeffective treatment of hcv remains a worldwide challenge despite the recent approval of new efficacious hcv therapies cytomegalovirus cmv cmv disease is a common condition postrenal transplant despite prophylaxis rsv the cdc reported the highest number of rsv in the united states in the past  years due to an increasing number of individuals not vaccinated rhabodviruses rabies  deathsyear confirmed by world health organization human immunodeficiency virus hiv laboratory evaluation has demonstrated that ranpirnase is effective in inhibiting infection of epithelial cells by human immunodeficiency virus hiv this approach will serve important in using topical ranpirnase to prevent the spread of hiv     back to top news  tamir biotechnology inc news topical ranpirnase demonstrates effective treatment of hpv associated genital warts tamirbio march   news phase iii data presented at  latebreaking research at american academy of dermatology short hills nj march  – tamir biotechnology a leading developer of antiviral therapies presented data demonstrating the safety and efficacy of topical ranpirnase in the treatment of hpv associated genital warts during the  american academy of dermatology latebreaking research session the company’s leading asset topical ranpirnase was evaluated in a formal phase iii double blinded investigation in seventyfive  immunocompetent subjects with genital warts patients received either topical ranpirnase or vehicle control with twice a day application to the affected area for a period of eight  weeks the dose of ranpirnase was mgweek more… continue reading press release ranpirnase shows antiviral effect against ebola tamirbio july   news san diego ca — tamir biotechnology a leading developer of antiviral therapies announced today the publication in the peer reviewed journal antiviral research of ranpirnase activity against the ebola virus in this study involving both laboratory invitro and an established animal invivo model of ebola infection the authors confirmed the ability of ranpirnase to inhibit viral replication of ebola reduce virus levels of ebola of infected mice and significantly extend survival times of animals treated with ranpirnase compared to a control animal group more… continue reading ranpirnase exhibits antizika activity tamirbio february   news san diego feb   prnewswire — tamir biotechnology a clinical stage company developing ranpirnase as a novel broadspectrum antiviral announced results today from a preclinical investigational study at the institute of antiviral research at utah state university read the full article here from prnewswirecom continue reading tamir biotechnology provides update on tmr development against mutating ebola tamirbio may   news san diego april   prnewswire — tamir biotechnology a leading developer of rna modulating drugs announced today an update on its ebola antiviral therapy program read the full article here from prnewswirecom continue reading new antiviral medication for hpv infection shows promise tamirbio april   news medicalresearchcom interview with luis squiquera md tamir biotechnology medicalresearch what is the background for this study what are the main findings dr squiquera ranpirnase is a small peptide that has a characteristic enzymatic activity against double stranded rna dsrna as a drug it has been extensively tested intravenously in high concentration for oncology in over  patients with different types of malignancy especially mesothelioma with minimal side effects and mainly a transient increase of serum creatinine level observed read the full article here from medicalresearchcom continue reading antiviral promising in early hpv trial tamirbio april   news san francisco — the experimental antiviral drug ranpirnase can completely clear away the warts caused by human papillomavirus hpv a preliminary study has shown if these results are borne out in further studies ranpirnase would be the first drug to attakc hpv itself said eric daniels md a research consultant for tamir biotechnology in san diego read the full article here pdf from wwwmedscapecom continue reading aad frog enzyme clears genital warts tamirbio april   news san francisco — threefourths of men with anogenital warts caused by human papillomavirus hpv had clinical remission and the rest had partial responses to a frogderived enzyme investigators reported here clinical remission occurred in  of  evaluable patients in response to ranpirnase an endoribonuclease derived from the eggs of rana pipiens or northern leopard frog the patients received  mgml bid of a topical formulation of ranpirnase and remissions occurred on average within  days of starting treatment luis squiquera md of tamir biotechnology reported at the american academy of dermatology meeting read the full article here from wwwmedpagetodaycom continue reading categories news recent posts topical ranpirnase demonstrates effective treatment of hpv associated genital warts press release ranpirnase shows antiviral effect against ebola ranpirnase exhibits antizika activity tamir biotechnology provides update on tmr development against mutating ebola new antiviral medication for hpv infection shows promise archives march   july   february   may   april   back to top tamir biotechnology inc  high bluff dr san diego ca biological products  mapquest tamir biotechnology inc  high bluff dr san diego ca  reviews   website menu  reservations make reservations order online tickets tickets see availability nearby directions  sponsored topics see a problem let us know tamir biotechnology inc formerly alfacell corporation is the first company to advance a biopharmaceutical product candidate that works in a manner similar to rna interference rnai through latestage clinical trials the product candidate onconase is an rnase that overcomes the challenges of targeting rna for therapeutic purposes while enabling the development of a new class of targeted therapies for cancer viruses and other lifethreatening diseases legal help tamir biotechnology inc  revenue and financial reports  db hoovers menu buy reports  lists how it works united states united kingdom   login company people industry search db hoovers company  people  industry login avention onesource is now db hoovers login here for access to db hoovers db datavision db business browser and isell login for customers of hoovers prior to march   login call   chat software by boldchat start free trial call   chat software by boldchat start free trial search the db hoovers database company company people industry home company information company search company overview  revenue  financial data company profile information for sales preparation marketing contacts competition revenue  financial available products company report biotechnology product manufacturing industry report tamir biotechnology inc revenue and financial data developmentstage tamir biotechnology formerly alfacell is willing to kiss a few frogs in hopes one will transform into a princely product the biotechnology firm has isolated proteins from northern leopard frog eggs and embryos as possible therapies for cancerous tumors that have become resistant to chemotherapy the companys lead drug candidate onconase is being studied as a possible treatment for a variety of cancers including nonsmall cell lung cancer tamir biotechnology is researching applications for onconase and other amphibian proteins for applications in other areas of oncology as well as infectious diseases financials information for tamir biotechnology inc track this company’s financial condition view company report request your free trial income statement cash flowbalance sheetcredit rating income statement mil revenue  gross profit  operating income  net income  diluted eps  cash flow mil cash at the beginning of the year  net operating cash  net investing cash  net financing cash  net change in cash  cash at end of the year  capital expenditure  assets mil current assets cash  net receivables  inventories  other income assets  asset summary total current assets  net fixed assets  other noncurrent assets  total assets  liabilities mil current liabilities accounts payable  short term debt  other current liabilities  liability summary total current liabilities  long term debt  other noncurrent liabilities  total liabilities  stakeholders equity mil equity preferred stock equity  common stock equity  equity summary total equity  shares outstanding credit rating low these businesses have a low projected risk of delinquency and a moderate to low risk of failure need to go deeper no problem save time with complex financial data at your fingertips access financial statements sec filings earnings estimates and more call   to talk to a business information consultant request your free trial   free alerts to changes in your db® credit scores sign up get creditsignal® for free try db credit free for  days get started try db credit free for  days